Logs determine water flow behind pipe in AlaskaSCHNORR, D. R.Oil & gas journal. 1993, Vol 91, Num 45, pp 77-81, issn 0030-1388Article

Optimizing water injection profiles with oxygen activation loggingSCHNORR, D. R.Production operation symposium. 1995, pp 683-691Conference Paper

LYMPHOGRAPHIE BEI PROSTATAKARZINOMEN. II. BEITRAG ZUR INDIREKTEN LYMPHOGRAPHIE (PROSTATALYMPHOGRAPHIE). = LYMPHOGRAPHIE DANS LES CANCERS DE LA PROSTATE. I. CONTRIBUTION A LA LYMPHOGRAPHIE INDIRECTE (LYMPHOGRAPHIE PROSTATIQUE)WESIROW G; LUENING M; SCHNORR D et al.1977; RADIOL. DIAGNOST.; ALLEM.; DA. 1977; VOL. 18; NO 5; PP. 617-626; ABS. RUSSE ANGL.; BIBL. 1 P.Article

EVOCABILITY OF A SLIGHT POSITIVE OESTROGEN FEEDBACK ACTION ON LH SECRETION IN CASTRATED AND OESTROGEN-PRIMED MEN.DOERNER G; ROHDE W; SCHNORR D et al.1975; ENDOKRINOLOGIE; DTSCH.; DA. 1975; VOL. 66; NO 3; PP. 373-376; BIBL. 7 REF.Article

DIE PROSTATALYMPHOGRAPHIE. BEITRAG ZUR INDIREKTEN LYMPHOGRAPHIE. = LA LYMPHOGRAPHIE PROSTATIQUE. CONTRIBUTION A LA LYMPHOGRAPHIE INDIRECTEWESIROW G; LUNING M; SCHNORR D et al.1977; DTSCHE GESUNDH.-WES.; DTSCH.; DA. 1977; VOL. 32; NO 6; PP. 258-263; ABS. RUSSE ANGL.; BIBL. 40 REF.Article

MODERNE ASPEKTE DER DIAGNOSTIK UND THERAPIE DES PROSTATA-KARZINOMS. = ASPECTS MODERNES DU DIAGNOSTIC ET DU TRAITEMENT DU CANCER DE LA PROSTATESCHNORR D; GUDDAT HM; LENK S et al.1977; ZBL. CHIR.; DTSCH.; DA. 1977; VOL. 102; NO 6; PP. 326-331; ABS. ANGL.; BIBL. 2 P.Article

EVALUATION OF A COMPETITIVE BINDING ASSAY FOR CORTISOL USING HORSE TRANSCORTINSTAHL F; HUBL W; SCHNORR D et al.1978; ENDOKRINOLOGIE; DDR; DA. 1978; VOL. 72; NO 2; PP. 214-222; BIBL. 15 REF.Article

ERSTER ERFAHRUNGSBERICHT UEBER EIN DIAGNOSE- UND THERAPIESCHEMA BEI METASTASIEREDEM PROSTATAKARZINOM = PREMIER RAPPORT DE L'EXPERIENCE DES SCHEMAS DE DIAGNOSTIC ET DE TRAITEMENT DANS LES CARCINOMES PROSTATIQUES AVEC METASTASESCORRENS HJ; BUCHALI K; SCHNORR D et al.1978; RADIOBIOL. RADIOTHERAP.; DDR; DA. 1978; VOL. 19; NO 5; PP. 638-640Article

ERSTE ERFAHRUNGEN MIT AETHINYLOESTRADIOLSULFONAT (596) BEI DER THERAPIE DES PROSTATAKARZINOMS = RESULTATS PRELIMINAIRES DU TRAITEMENT DE TUMEURS DE LA PROSTATE PAR LE SULFONATE D'ETHINYLOESTRADIOLGUDDAT HM; SCHNORR D; DOERNER G et al.1979; Z. UROL. NEPHROL.; DDR; DA. 1979; VOL. 72; NO 3; PP. 153-157; ABS. RUS/ENG; BIBL. 22 REF.Article

BEEINFLUSSUNG DER MAENNLICHEN FERTILITAET UND SEXUALITAET DURCH ORAL WIRKSAME ANTIANDROGENE BEI RATTE UND MENSCH = L'INFLUENCE DES ANTIANDROGENES EFFICACES ORALEMENT SUR LA FERTILITE ET LA SEXUALITE MASCULINES DU RAT ET DE L'HOMMEENGEL S; GOTZ F; STAHL F et al.1978; DERMATOL. MONATSSCHR.; DDR; DA. 1978; VOL. 164; NO 8; PP. 574-577; ABS. ENG; BIBL. 12 REF.Article

2 JAHRE ERFAHRUNG MIT DER ⁸⁹SR-THERAPIE VON MULTIPLEN KNOCHENMETASTASEN = DEUX ANNEES D'EXPERIENCE DE TRAITEMENT PAR LE ⁸⁹SR DES METASTASES MULTIPLES OSSEUSESCORRENS HJ; MITTERLECHNER E; BUCHALI K et al.1979; RADIOBIOL. RADIOTHERAP.; DDR; DA. 1979; VOL. 20; NO 3; PP. 360-362; ABS. RUS/ENG; BIBL. 8 REF.Article

DIAGNOSTIK UND THERAPIE DES PROSTATAKARZINOMS = DIAGNOSTIC ET TRAITEMENT DU CANCER DE LA PROSTATESCHNORR D; GUDDAT HM; NEUSER D et al.1979; ZBL. CHIR.; DDR; DA. 1979; VOL. 107; NO 4; PP. 436-445; ABS. ENG; BIBL. 20 REF.Article

Dehydroepiandrosterone (DHEA) levels in patients with prostatic cancer, heart diseases and under surgery stressSTAHL, F; SCHNORR, D; PILZ, C et al.Experimental and clinical endocrinology. 1992, Vol 99, Num 2, pp 68-70, issn 0232-7384Article

Evaluating high-angle wells with advanced production-logging technologyHUPP, D; SCHNORR, D. R.SPE annual technical conference. 1999, pp 951-963Conference Paper

The effective use of pulse neutron logging for fluid surveillance in a low-salinity environment, Endicott, AlaskaCUNNINGHAM, A. B; SCHNORR, D. R.64th Annual Western Regional Meeting. 1994, pp 543-553Conference Paper

Relation of free PSA/total PSA in serum for differentiating between patients with prostatic cancer and benign hyperplasia of the prostate : Which cutoff should be used?LEIN, M; STEPHAN, C; JUNG, K et al.Cancer investigation. 1998, Vol 16, Num 1, pp 45-49, issn 0735-7907Article

Soluble CD44 variants in the serum of patients with urological malignanciesLEIN, M; JUNG, K; WEISS, S et al.Oncology. 1997, Vol 54, Num 3, pp 226-230, issn 0030-2414Article

Anwendung der optischen Kohärenztomographie (OCT) bei der Darstellung von Urothelerkrankungen der Harnblase = Utilizing optical coherence tomography (OCT) for visualization of urothelial diseases of the urinary bladderDANILTCHENK, D; KÖNIG, F; LANKENAU, E et al.Der Radiologe (Berlin. Print). 2006, Vol 46, Num 7, pp 584-589, issn 0033-832X, 6 p.Article

Advanced cecal carcinoma mimicking Peyronie's diseaseGRALLA, O; ROEMER, A; KLUENER, C et al.The Journal of urology. 2004, Vol 172, Num 3, issn 0022-5347, p. 936Article

Staging von Harnblasentumoren in der MRT: Wertigkeit der intravesikalen Applikation von eisenoxidhaltigem Kontrastmittel in Kombination mit hochaufgelöster T₂-gewichteter Bildgebung = Staging of urinary bladder tumors by MRI: utility of intravesical administration of an iron oxide-containing contrast Medium in Combination with High-Resolution, T₂-Weighted ImagingBEYERSDORFF, D; TAUPITZ, M; GIESSING, M et al.Rofo. Fortschritte auf dem Gebiet der Rontgenstrahlen und der bildgebenden Verfahren. 2000, Vol 172, Num 6, pp 504-508, issn 1438-9029Article

Preanalytical determinants of total and free prostate-specific antigen and their ratio : Blood collection and storage conditionsJUNG, K; VON KLINGGRÄFF, P; BRUX, B et al.Clinical chemistry (Baltimore, Md.). 1998, Vol 44, Num 3, pp 685-688, issn 0009-9147Article

Soluble CD44 molecules in serum of patients with prostate cancer and benign prostatic hyperplasiaJUNG, K; LEIN, M; WEISS, S et al.European journal of cancer (1990). 1996, Vol 32, Num 4, pp 627-630, issn 0959-8049Article

Suppression of plasma androgen levels with a combination therapy of depot-estrogen (Turisteron^R) and dexamethasone^R in patients with prostatic cancerSTAHL, F; SCHNORR, D; BAÊR, C.-M et al.Experimental and clinical endocrinology. 1989, Vol 94, Num 3, pp 239-243, issn 0232-7384, 5 p.Article

Results of a double blind study of 89-strontium therapy of skeletal metastases of prostatic carcinomaBUCHALI, K; CORRENS, H.-J; SCHUERER, M et al.European journal of nuclear medicine. 1988, Vol 14, Num 7-8, pp 349-351, issn 0340-6997Article

Ratio of free-to-total prostate specific antigen in serum cannot distinguish patients with prostate cancer from those with chronic inflammation of the prostateJUNG, K; MEYER, A; LEIN, M et al.The Journal of urology. 1998, Vol 159, Num 5, pp 1595-1598, issn 0022-5347Article